Search
Showing results for "Professor"
Research
Developmental respiratory physiologyVarious developmental aspects of respiratory physiology put infants and young children at an increased risk of respiratory failure, which is associated with a higher rate of critical incidents during anesthesia.
Research
Development and validation of a miniaturized bacteriophage host range screening assay against antibiotic resistant Pseudomonas aeruginosaAntimicrobial resistance is a current global health crisis, and the increasing emergence of multidrug resistant infections has led to the resurgent interest in bacteriophages as an alternative treatment.
Research
Antimicrobial susceptibility of Moraxella catarrhalis isolated from children in Kalgoorlie-BoulderTo investigate antimicrobial susceptibility of Moraxella catarrhalis isolated from a cohort of children being followed in a study of the natural history of OM
Research
Common mental disorders: missed opportunity for smoking prevention and cessationCommon mental disorders: missed opportunity for smoking prevention and cessation

Research
Defining the microbes in the middle ear and upper respiratory tract that lead to recurrent ear infections – a metagenomic studyUsing the latest sequencing technology to examine the microbial composition of the middle ear & nasopharyngeal region, the site of initial colonization of OM
The newly created role of Clinical Services Manager will lay the groundwork for an exciting new early intervention centre for kids showing early signs of autism

News & Events
Calling All Budding ArtistsCalling all budding artists - submit your child's artwork to win!

News & Events
Ten Day Continuous Glucose Monitoring study – now recruitingThe Children’s Diabetes Centre is now recruiting for a new continuous glucose monitoring study.

Our team is comprised of well experienced clinicians who can support your child and family.
Research
Pseudomonas aeruginosa Resistance to Bacteriophages and Its Prevention by Strategic Therapeutic Cocktail FormulationAntimicrobial resistance poses a significant threat to modern healthcare as it limits treatment options for bacterial infections, particularly impacting those with chronic conditions such as cystic fibrosis (CF). Viscous mucus accumulation in the lungs of individuals genetically predisposed to CF leads to recurrent bacterial infections, necessitating prolonged antimicrobial chemotherapy. Pseudomonas aeruginosa infections are the predominant driver of CF lung disease, and airway isolates are frequently resistant to multiple antimicrobials.